Message From Managing Director

Manish Gupta
Managing Director

We are now pure-play animal health company with an annual turnover in the region of Rs.1180 crores or $165mn, making us the largest in India and 20th largest animal health company across the globe. We have a track-record of consistent performance over last 12 quarters, ever since we became a pure-play animal health company.

We began this journey with a vision of creating a world-class animal health company, and today, this ambition is fulfilled as we ended the FY-20 with a performance commensurate with our commitment. It is a validation of our unique business model as also our execution capabilities that we have achieved this in a challenging environment of multiple headwinds.

The SeQuent that you see today has metamorphosed from an India-centric, API-led firm serving the unregulated markets to a global animal health company underpinned by a vertically integrated strategy, focus on formulations and worldwide footprint. This transformation has been catalysed by our strategic investments in building our Vizag API facility as well as the inorganic acquisitions across the globe, complemented by the successful integration of these acquisitions.

On the formulations front, our business has shown tremendous growth on the back of performance across all geographies. Our growth was driven by improved market shares across key products as also new product introductions. We have established strong R&D capabilities in India and Spain which complements our manufacturing footprints in India, Spain, Turkey, Germany and Brazil.

I believe with Carlyle as the new promoter group we are well poised to a new phase of development, where we together with Carlyle will work to grow the company into one of the top global animal healthcare companies. Carlyle is no stranger to the Indian Healthcare sector with a history of investing in the healthcare sector, both in India and globally, fueled by a deep understanding of the market and an ability to create value through its operational expertise and close partnerships with management. This transaction is their largest control deal in India and is reflective of their confidence on the sector as well the business model of Sequent.